Genes potentially associated with resistance of lung cancer cells to paclitaxel

Abstract

105 Paclitaxel is a natural substance from the group of taxanes and one of the most widely used drugs in che motherapy of malignant tumors, including the non small cell lung cancer (NSCLC). Treatment of patients with advanced NSCLC with paclitaxel alone or in combination with other drugs led to complete or partial tumor regression in at most 41% of patients… (More)
DOI: 10.1134/S1607672911020153

Topics

3 Figures and Tables

Cite this paper

@article{Kashkin2011GenesPA, title={Genes potentially associated with resistance of lung cancer cells to paclitaxel}, author={Kirill N. Kashkin and El{\'e}na Musatkina and Andrei V Komelkov and Dmitry A. Sakharov and Evgeny V Trushkin and Evgeny A Tonevitsky and T. V. Vinogradova and Evgenij P Kopantzev and M. V. Zinovyeva and Olga V Kovaleva and Ksenia A Arkhipova and Irina B. Zborovskaya and Alexander G. Tonevitsky and E. D. Sverdlov}, journal={Doklady Biochemistry and Biophysics}, year={2011}, volume={437}, pages={105-108} }